Written by Ralph Orlowski
BioNtech SE, Europe’s largest unlisted biotech firm by staff numbers, said on Tuesday that it planned to raise up to $303.6 million in an initial public offering in the United States.
The company expects its offering …
Written by Ben Winck
Since 1950, all nine major US recession have been preceded by an inversion of a key segment of the so-called yield curve.
Defined as the spread between long- and short-dated Treasury bonds, the yield curve turns …
Written by Sam Fleming, Gemma Tetlow, Steven Bernard, Tom Pearson, and Jennifer Bissell
The FT’s one-stop overview of key US economic data and trends, including GDP, inflation, unemployment, consumer indicators, and the outlook for US interest rates and mortgage rates
Click here to read more.
Written by Amgen
THOUSAND OAKS, Calif., Aug. 26, 2019 /PRNewswire/ — Amgen (NASDAQ: AMGN) announced today that it has entered into an agreement with Celgene Corporation (NASDAQ: CELG) in connection with its previously announced merger with Bristol-Myers Squibb Company (NYSE: BMY) to acquire worldwide rights to Otezla® (apremilast), the …
Written by Frank Vinluan
Vertex Pharmaceuticals is paying $950 million to acquire Semma Therapeutics, a biotech startup developing a stem cell therapy for type 1 diabetes.
The deal announced Tuesday is Vertex’s first step into the diabetes field and is …